Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Benjamin Walbaum"'
Autor:
Karol Ramirez-Parada, Angela Gonzalez-Santos, Layla Riady-Aleuy, Mauricio P. Pinto, Carolina Ibañez, Tomas Merino, Francisco Acevedo, Benjamin Walbaum, Rodrigo Fernández-Verdejo, Cesar Sanchez
Publikováno v:
Current Oncology, Vol 30, Iss 9, Pp 8068-8077 (2023)
Breast cancer-related lymphedema (BCRL) is characterized by arm swelling, pain, and discomfort, reducing the quality of life (QoL) of affected individuals. BRCL is caused via the blockage or disruption of the lymphatic vessels following cancer treatm
Externí odkaz:
https://doaj.org/article/720a1b09200d44f49d70adab3a11e484
Autor:
Carmen Vega, Esteban Barnafi, César Sánchez, Francisco Acevedo, Benjamin Walbaum, Alejandra Parada, Nicolás Rivas, Tomás Merino
Publikováno v:
Nutrients, Vol 16, Iss 4, p 477 (2024)
This study assesses the feasibility of calorie restriction (CR) and time-restricted feeding (TRF) in overweight and obese cancer patients who realized little to no physical activity undergoing curative radiotherapy, structured as a prospective, inter
Externí odkaz:
https://doaj.org/article/482582e7fe6c483e9f7cea66afcb27f8
Publikováno v:
Cancer Research. 83:P4-07
BACKGROUND: Breast cancer (BC) is the most common cancer diagnosed in premenopausal women with an increasing incidence for age 35 or less. Although proportionally less frequent, hormone receptor (HR)–positive BC still remains the main subtype for t
Autor:
FRANCISCO ACEVEDO, Benjamin Walbaum, Lidia Medina, Tomas Merino, Catherine Bauerle, Mauricio Camus, Augusto Leon, Manuel Manzor, Paulina Veglia, Raul Martinez, Constanza Guerra, Marisel Navarro, Francisco Dominguez, CÉSAR SÁNCHEZ
Publikováno v:
Cancer Research. 83:P1-11
Background Standard treatment in early HER2 positive BC involves the use of neoadjuvant chemotherapy (NACT) with Trastuzumab (T) plus Pertuzumab (P). Dual blockade increases pathological complete response (pCR) and improves disease free survival (DFS
Autor:
Benjamin Walbaum G., Francisco Acevedo C., Diego Carrillo B., Mauricio Camus A., Manuel Manzor V., Raul Martínez R., Paulina Veglia Q., Geraldine Murature S., Valentina Salvado U., Sabrina Muñiz M., Tomás Merino L., Cesar Sanchez Rojel
Publikováno v:
Revista de Cirugía. 75
El cáncer de mama (CM) es la primera causa de muerte por cáncer en mujeres tanto a nivel mundial como en Chile. Basados en características clínicas, histológicas y moleculares, múltiples estudios han identificado cuatro subtipos básicos de CM,
Autor:
Glomaryeth Luque S.1, Benjamin Walbaum G.2, Mauricio Camus A.1, Francisco Domínguez C.1, Tomas Merino L.2, Francisco Acevedo C.2, César Sánchez R.2 cgsanchezr@gmail.com
Publikováno v:
Revista de Cirugia. 2021, Vol. 73 Issue 2, p188-196. 9p.
Autor:
Benjamin Walbaum, Maria Jose Guzman, Zachary J. Ward, Jorge Jiménez de la Jara, Rifat Atun, Bruno Nervi, Magdalena Walbaum
Publikováno v:
The Lancet Oncology. 22:1427-1437
Summary Background The COVID-19 pandemic has strained health system capacity worldwide due to a surge of hospital admissions, while mitigation measures have simultaneously reduced patients' access to health care, affecting the diagnosis and treatment
Publikováno v:
Cancer Research. 81:PS6-37
INTRODUCTION In breast cancer (BC) patients, achieving a complete pathological response (pCR) after neoadjuvant chemotherapy (NCT) is associated with better prognosis. Despite this, some of these patients will experience recurrences of the disease an
Autor:
Benjamin Walbaum, FRANCISCO ACEVEDO, Catherine Bauerle, Mauricio Camus, Manuel Manzor, Raul Martinez, Paulina Veglia, Marisel Navarro, Constanza Guerra, Francisco Dominguez, Tomas Merino, Lidia Medina, CÉSAR SÁNCHEZ
Publikováno v:
Cancer Research. 83:P3-03
Background: triple-negative breast cancer (TNBC) is associated with hereditary and environmental risk factors plus an overall worse prognosis compared to other Breast Cancer (BC) subtypes. While TNBC risk factors, prevalence, clinical characteristics
Autor:
FRANCISCO ACEVED, Benjamin Walbaum, Lidia Medina, Tomas Merino, Paula Reyes, Militza Petric, Francisco Dominguez, Paulina Gonzalez, CÉSAR SÁNCHEZ
Publikováno v:
Cancer Research. 83:P6-02
Introduction 10% of Breast Cancer (BC) cases are thought to carry a germline pathogenic variant (PV) in a susceptibility gene. Most clinicians utilize the National Comprehensive Cancer Network (NCCN) guidelines criteria to both identify these patient